Lawrence Kenyon - Chief Financial Officer, Director at Outlook Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer, Director
Stock Symbol
OTLK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Lawrence Kenyon - trading volume in the past year for Outlook Therapeutics, Inc.

Holdings reported by Lawrence Kenyon for Outlook Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.95K $33.8K $5.69 Sep 26, 2024 Direct
Stock Option (Right to Buy) 12.5K Mar 20, 2024 Direct Common Stock

Transactions reported by Lawrence Kenyon for Outlook Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.